Viusid + Glizigen

Viusid + Glizigen is a **combination therapy** composed of Viusid, an oral nutritional supplement with purported immunostimulant, antioxidant, and antiviral effects, and Glizigen, a topical preparation based primarily on glycyrrhizinic acid (from licorice root), which has known antiviral and anti-inflammatory properties. - Viusid is formulated to **support immune system function** using a blend of antioxidants and agents such as glycyrrhizinic acid, ascorbic acid, B vitamins, amino acids, and other compounds with claimed antiviral activity[1][4]. - Glizigen is used topically and primarily contains glycyrrhizinic acid. It is promoted for its antiviral, anti-inflammatory, and antioxidative properties[1][3]. - As a combination, Viusid + Glizigen is most frequently studied and used for the **treatment of anogenital warts** (external genital warts) caused by human papillomavirus (HPV), as well as investigated for high-grade cervical intraepithelial lesions associated with HPV infection[1][2][3]. - Mechanistically, the combination acts primarily by *topical antiviral action (glycyrrhizinic acid on lesions) and systemic immune modulation (via oral antioxidants and purported immunostimulation)*. The precise mechanism is not fully elucidated in high-quality literature[1][3][4]. - Viusid + Glizigen is not considered a pharmaceutical in the strict sense, but rather a **combination of a dietary supplement and a topical preparation with claimed medicinal properties**; clinical trials have focused largely on efficacy in HPV-related lesions[1][2][4].

Brand names

Viusid + Glizigen

Other names

Glizigen-ViusidGlizigen plus Viusid